Ganeden Biotech announces 19th peer-reviewed published study
CLEVELAND, OH (October 30, 2014) - Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, is pleased to reveal that their 19th peer-reviewed study has been published in Anaerobe (The Official Journal of the Anaerobe Society of the Americas). This study, conducted by Dr. Glenn Gibson, professor at the University of Reading, England; in their validated intestinal model, demonstrated that there are benefits to taking GanedenBC30 and prebiotics together versus taking prebiotics alone.
Prebiotics are specialized plant fibers that beneficially nourish good bacteria, and are a source of food for the healthy bacterial species that reside within the intestinal tract. Common prebiotics include FOS (fructooligosaccharides), GOS (galactooligosaccharides) and inulin (chicory root or agave).
Prebiotics have been shown to increase healthy bacterial species such as lactobacilli and bifidobacteria. In this study, bacterial flora changes were analyzed with prebiotics alone as well as with prebiotics plus GanedenBC30. While there were increases in lactobacilli and bifidobacteria in both cases, there were additional increases in other good bacterial strains (such as Faecalibacterium prausnitzii- and important bacteria for intestinal health) when consumed along with GanedenBC30. In addition, prebiotic activity was increased when consumed with GanedenBC30 as measured by an increase in short chain fatty acids; which are important components for intestinal health.
“This study is exciting, as it lays the groundwork for continuing our research into the combined benefits of GanedenBC30 and prebiotics.” said David Keller, VP of Scientific Operations at Ganeden Biotech. “We are well aware of both the benefits of GanedenBC30 and the benefits of prebiotics separately; but now we have data showing increased digestive benefits of consuming them together”.
To request the full study, please click here.
###
About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden’s newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit GanedenBiotech.com.
About GanedenBC30
Introducing GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden Biotech’s patented probiotic ingredient that can be found in more than 100 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains, GanedenBC30 is a spore-forming organism which makes it highly stable and allows it remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 19 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage and companion animal product that experiences high or low temperature, pressure or environmental extremes including all hot or refrigerated beverages! For more information, please visit GanedenBiotech.com or GanedenBC30.com.
Help employers find you! Check out all the jobs and post your resume.
